Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA - PubMed (original) (raw)
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
C S Chu et al. Nat Genet. 1993 Feb.
Abstract
Variable in-frame skipping of exon 9 in cystic fibrosis transmembrane conductance regulator (CFTR) mRNA transcripts (exon 9-) occurs in the respiratory epithelium. To explore the genetic basis of this event, we evaluated respiratory epithelial cells and blood leukocytes from 124 individuals (38 with cystic fibrosis (CF), 86 without CF). We found an inverse relationship between the length of the polythymidine tract at the exon 9 splice branch/acceptor site and the proportion of exon 9- CFTR mRNA transcripts. These results strongly indicate a genetic basis in vivo modulating post-transcriptional processing of CFTR mRNA transcripts.
Similar articles
- Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Strong TV, Smit LS, Nasr S, Wood DL, Cole JL, Iannuzzi MC, Stern RC, Collins FS. Strong TV, et al. Hum Mutat. 1992;1(5):380-7. doi: 10.1002/humu.1380010506. Hum Mutat. 1992. PMID: 1284540 - A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
Will K, Dörk T, Stuhrmann M, Meitinger T, Bertele-Harms R, Tümmler B, Schmidtke J. Will K, et al. J Clin Invest. 1994 Apr;93(4):1852-9. doi: 10.1172/JCI117172. J Clin Invest. 1994. PMID: 7512993 Free PMC article. - [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
Romey MC. Romey MC. Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):429-37. Ann Biol Clin (Paris). 2006. PMID: 17040873 Review. French. - [Molecular basis of cystic fibrosis].
Bal J. Bal J. Postepy Biochem. 1991;37(3-4):153-8. Postepy Biochem. 1991. PMID: 1725923 Review. Polish. No abstract available.
Cited by
- The Role of Pancreatitis Risk Genes in Endocrine Insufficiency Development After Acute Pancreatitis in Children.
Abu-El-Haija M, Zhang W, Karns R, Ginzburg G, Vitale DS, Farrell P, Nasr A, Ibrahim S, Bellin MD, Thompson T, Garlapally V, Woo JG, Husain SZ, Denson LA. Abu-El-Haija M, et al. Clin Gastroenterol Hepatol. 2024 Oct;22(10):2033-2043.e2. doi: 10.1016/j.cgh.2024.05.039. Epub 2024 Jun 12. Clin Gastroenterol Hepatol. 2024. PMID: 38871151 - High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program.
Hendifar A, Hitchins M, Lauzon M, Hatchell KE, Heald B, Pandol S, Naren AP, Osipov A. Hendifar A, et al. HPB (Oxford). 2024 Aug;26(8):1082-1085. doi: 10.1016/j.hpb.2024.05.005. Epub 2024 May 21. HPB (Oxford). 2024. PMID: 38825435 Free PMC article. No abstract available. - Compound heterozygous mutations in CFTR causing congenital bilateral absence of the vas deferens in a Chinese pedigree.
Li L, Qu X, Cui C, Feng K, Xia Y, Wan F, Ge H, Fang Y, Zhang C, Guo H. Li L, et al. Mol Genet Genomic Med. 2024 Jan;12(1):e2364. doi: 10.1002/mgg3.2364. Mol Genet Genomic Med. 2024. PMID: 38284450 Free PMC article. - The dominant findings of a recessive man: from Mendel's kid pea to kidney.
Tory K. Tory K. Pediatr Nephrol. 2024 Jul;39(7):2049-2059. doi: 10.1007/s00467-023-06238-9. Epub 2023 Dec 5. Pediatr Nephrol. 2024. PMID: 38051388 Free PMC article. Review. - Compound heterozygous variants in CFTR with potentially reducing ATP-binding ability identified in Chinese infertile brothers with isolated congenital bilateral absence of vas deferens.
Shengjia S, Lei W, Tianwei W, Hongmei W, Juanzi S, Sen Q. Shengjia S, et al. Mol Genet Genomic Med. 2023 Nov;11(11):e2249. doi: 10.1002/mgg3.2249. Epub 2023 Jul 24. Mol Genet Genomic Med. 2023. PMID: 37489040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical